Sridhar VS, Heerspink HJL, Davies MJ, Banks P, et al. The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3. Diabetes Care 2023 May 12:dc230129. doi: 10.2337/dc23-0129.
PMID: 37172207